TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Biopharmaceutical Contract Manufacturing Market – By Product
1.3.2 Global Biopharmaceutical Contract Manufacturing Market – By Service
1.3.3 Global Biopharmaceutical Contract Manufacturing Market – By Source
1.3.4 Global Biopharmaceutical Contract Manufacturing Market – By Geography
2. Biopharmaceutical Contract Manufacturing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Biopharmaceutical Contract Manufacturing – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America – PEST Analysis
4.3 Expert Opinion
5. Biopharmaceuticals Contract Manufacturing Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Outsourcing by Pharmaceutical Companies
5.1.2 Increasing Demand for Biologics
5.2 Market Restraints
5.2.1 Growing Competition in Industry
5.3 Market Opportunities
5.3.1 Emerging Markets
5.4 Future Trends
5.4.1 Consolidation in Pharmaceutical CMO Industry
5.4.2 COVID-19 Pandemic
5.5 Impact Analysis
6. Biopharmaceutical Contract Manufacturing Market – Global Analysis
6.1 Global Biopharmaceutical Contract Manufacturing Market Revenue Forecast and Analysis
6.2 Global Biopharmaceutical Contract Manufacturing Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Biopharmaceuticals Contract Manufacturing Market Analysis – By Product
7.1 Overview
7.2 Biopharmaceuticals Contract Manufacturing Market Revenue Share, by Product (2021 and 2028)
7.3 Biologics
7.3.1 Overview
7.3.2 Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Monoclonal Antibodies
7.3.2.1.1 Overview
7.3.2.1.2 Monoclonal Antibodies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Recombinant Proteins
7.3.2.2.1 Overview
7.3.2.2.2 Recombinant Proteins: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Vaccines
7.3.2.3.1 Overview
7.3.2.3.2 Vaccines: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.3.2.4 Others
7.3.2.4.1 Overview
7.3.2.4.2 Others: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Biosimilar
7.4.1 Overview
7.4.2 Biosimilar: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8. Biopharmaceuticals Contract Manufacturing Market – By Service
8.1 Overview
8.2 Biopharmaceuticals Contract Manufacturing Market, by Service, 2021 and 2028 (%)
8.3 Process Development
8.3.1 Overview
8.3.2 Process Development: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Downstream Processing
8.3.2.1.1 Overview
8.3.2.1.2 Downstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Upstream Processing
8.3.2.2.1 Overview
8.3.2.2.2 Upstream Processing: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Fill and Finish Operations
8.4.1 Overview
8.4.2 Fill and Finish Operations: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Analytical and Quality Control Studies
8.5.1 Overview
8.5.2 Analytical and Quality Control Studies: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Packaging
8.6.1 Overview
8.6.2 Packaging: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
9. Biopharmaceuticals Contract Manufacturing Market – By Source
9.1 Overview
9.2 Biopharmaceuticals Contract Manufacturing Market, by Source, 2021 and 2028 (%)
9.3 Mammalian-Based Biologics
9.3.1 Overview
9.3.2 Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Microbial/Non-Mammalian-Based Biologics
9.4.1 Overview
9.4.2 Microbial/Non-Mammalian-Based Biologics: Biopharmaceuticals Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
10. Biopharmaceutical Contract Manufacturing Market – Geographic Analysis
10.1 North America: Biopharmaceutical Contract Manufacturing Market
10.1.1 Overview
10.1.2 North America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.3 North America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.1.3.1 North America: Biologics Market, 2019-2028 (USD Million)
10.1.4 North America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.1.4.1 North America: Process Development Market, 2019-2028 (USD Million)
10.1.5 North America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.1.6 North America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
10.1.6.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.1 US: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.2 US: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.1.6.1.2.1 US: Biologics Market, 2019-2028 (USD Million)
10.1.6.1.3 US: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.1.6.1.3.1 US: Process Development Market, 2019-2028 (USD Million)
10.1.6.1.4 US: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.1.6.2 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.1 Canada: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.2 Canada: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.1.6.2.2.1 Canada: Biologics Market, 2019-2028 (USD Million)
10.1.6.2.3 Canada: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.1.6.2.3.1 Canada: Process Development Market, 2019-2028 (USD Million)
10.1.6.2.4 Canada: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.1.6.3 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Mexico: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.2 Mexico: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.1.6.3.2.1 Mexico: Biologics Market, 2019-2028 (USD Million)
10.1.6.3.3 Mexico: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.1.6.3.3.1 Mexico: Process Development Market, 2019-2028 (USD Million)
10.1.6.3.4 Mexico: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2 Europe: Biopharmaceutical Contract Manufacturing Market
10.2.1 Overview
10.2.2 Europe: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.3.1 Europe: Biologics Market, 2019-2028 (USD Million)
10.2.4 Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.4.1 Europe: Process Development Market, 2019-2028 (USD Million)
10.2.5 Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6 Europe: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
10.2.6.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.1 Germany: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.1.2 Germany: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.1.2.1 Germany: Biologics Market, 2019-2028 (USD Million)
10.2.6.1.3 Germany: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.1.3.1 Germany: Process Development Market, 2019-2028 (USD Million)
10.2.6.1.4 Germany: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.2 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.1 UK: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.2.2 UK: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.2.2.1 UK: Biologics Market, 2019-2028 (USD Million)
10.2.6.2.3 UK: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.2.3.1 UK: Process Development Market, 2019-2028 (USD Million)
10.2.6.2.4 UK: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.3 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.1 France: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.3.2 France: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.3.2.1 France: Biologics Market, 2019-2028 (USD Million)
10.2.6.3.3 France: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.3.3.1 France: Process Development Market, 2019-2028 (USD Million)
10.2.6.3.4 France: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.4 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.1 Spain: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.4.2 Spain: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.4.2.1 Spain: Biologics Market, 2019-2028 (USD Million)
10.2.6.4.3 Spain: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.4.3.1 Spain: Process Development Market, 2019-2028 (USD Million)
10.2.6.4.4 Spain: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.5 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.1 Italy: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.5.2 Italy: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.5.2.1 Italy: Biologics Market, 2019-2028 (USD Million)
10.2.6.5.3 Italy: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.5.3.1 Italy: Process Development Market, 2019-2028 (USD Million)
10.2.6.5.4 Italy: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.2.6.6 Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.1 Rest of Europe: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.2.6.6.2 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.2.6.6.2.1 Rest of Europe: Biologics Market, 2019-2028 (USD Million)
10.2.6.6.3 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.2.6.6.3.1 Rest of Europe: Process Development Market, 2019-2028 (USD Million)
10.2.6.6.4 Rest of Europe: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market
10.3.1 Overview
10.3.2 Asia Pacific: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.3.1 Asia Pacific: Biologics Market, 2019-2028 (USD Million)
10.3.4 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.4.1 Asia Pacific: Process Development Market, 2019-2028 (USD Million)
10.3.5 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6 Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.1.2.1 China: Biologics Market, 2019-2028 (USD Million)
10.3.6.1.3 China: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.1.3.1 China: Process Development Market, 2019-2028 (USD Million)
10.3.6.1.4 China: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.2 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.2.2.1 Japan: Biologics Market, 2019-2028 (USD Million)
10.3.6.2.3 Japan: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.2.3.1 Japan: Process Development Market, 2019-2028 (USD Million)
10.3.6.2.4 Japan: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.3 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 India: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.3.2.1 India: Biologics Market, 2019-2028 (USD Million)
10.3.6.3.3 India: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.3.3.1 India: Process Development Market, 2019-2028 (USD Million)
10.3.6.3.4 India: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.4 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 South Korea: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 South Korea: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.4.2.1 South Korea: Biologics Market, 2019-2028 (USD Million)
10.3.6.4.3 South Korea: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.4.3.1 South Korea: Process Development Market, 2019-2028 (USD Million)
10.3.6.4.4 South Korea: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.5 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Australia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 Australia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.5.2.1 Australia: Biologics Market, 2019-2028 (USD Million)
10.3.6.5.3 Australia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.5.3.1 Australia: Process Development Market, 2019-2028 (USD Million)
10.3.6.5.4 Australia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.3.6.6.2.1 Rest of Asia Pacific: Biologics Market, 2019-2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.3.6.6.3.1 Rest of Asia Pacific: Process Development Market, 2019-2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market
10.4.1 Overview
10.4.2 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.3.1 Middle East & Africa: Biologics Market, 2019-2028 (USD Million)
10.4.4 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.4.1 Middle East & Africa: Process Development Market, 2019-2028 (USD Million)
10.4.5 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4.6 Middle East & Africa: Biopharmaceutical Contract Manufacturing Market Share by Country – 2021 & 2028, (%)
10.4.6.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.6.1.2.1 Saudi Arabia: Biologics Market, 2019-2028 (USD Million)
10.4.6.1.3 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.6.1.3.1 Saudi Arabia: Process Development Market, 2019-2028 (USD Million)
10.4.6.1.4 Saudi Arabia: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4.6.2 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 UAE: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2 UAE: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.6.2.2.1 UAE: Biologics Market, 2019-2028 (USD Million)
10.4.6.2.3 UAE: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.6.2.3.1 UAE: Process Development Market, 2019-2028 (USD Million)
10.4.6.2.4 UAE: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4.6.3 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 South Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2 South Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.6.3.2.1 South Africa: Biologics Market, 2019-2028 (USD Million)
10.4.6.3.3 South Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.6.3.3.1 South Africa: Process Development Market, 2019-2028 (USD Million)
10.4.6.3.4 South Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.2 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.4.6.4.2.1 Rest of Middle East and Africa: Biologics Market, 2019-2028 (USD Million)
10.4.6.4.3 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.4.6.4.3.1 Rest of Middle East and Africa: Process Development Market, 2019-2028 (USD Million)
10.4.6.4.4 Rest of Middle East and Africa: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.5 South and Central America: Biopharmaceutical Contract Manufacturing Market
10.5.1 Overview
10.5.2 South and Central America: Biopharmaceutical Contract Manufacturing Market - Revenue and Forecast to 2028 (US$ Million)
10.5.3 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.5.3.1 South and Central America: Biologics Market, 2019-2028 (USD Million)
10.5.4 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.5.4.1 South and Central America: Process Development Market, 2019-2028 (USD Million)
10.5.5 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.5.6 South and Central America: Biopharmaceutical Contract Manufacturing Market, by Country, 2021 & 2028 (%)
10.5.6.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.1 Brazil: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.1.2 Brazil: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.5.6.1.2.1 Brazil: Biologics Market, 2019-2028 (USD Million)
10.5.6.1.3 Brazil: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.5.6.1.3.1 Brazil: Process Development Market, 2019-2028 (USD Million)
10.5.6.1.4 Brazil: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.5.6.2 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.1 Argentina: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.2.2 Argentina: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.5.6.2.2.1 Argentina: Biologics Market, 2019-2028 (USD Million)
10.5.6.2.3 Argentina: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.5.6.2.3.1 Argentina: Process Development Market, 2019-2028 (USD Million)
10.5.6.2.4 Argentina: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
10.5.6.3 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.1 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market – Revenue and Forecast to 2028 (USD Million)
10.5.6.3.2 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Product, 2019-2028 (USD Million)
10.5.6.3.2.1 Rest of South and Central America: Biologics Market, 2019-2028 (USD Million)
10.5.6.3.3 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Service, 2019–2028 (USD Million)
10.5.6.3.3.1 Rest of South and Central America: Process Development Market, 2019-2028 (USD Million)
10.5.6.3.4 Rest of South and Central America: Biopharmaceutical Contract Manufacturing Market, by Source, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Biopharmaceutical Contract Manufacturing Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Biopharmaceutical Contract Manufacturing Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 Boehringer Ingelheim International GmbH
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 General Electric Company
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 MERCK KGAA
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Lonza
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Samsung Biologics
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 AbbVie Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 WUXI BIOLOGICS
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Ajinomoto Co. Inc.
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Inno Bio Ventures Sdn Bhd
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES.
Table 1. North America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. North America Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 3. North America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 6. US Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 7. US Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 8. US Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 9. US Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 10. US Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 12. Canada Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 13. Canada Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 14. Canada Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 15. Canada Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 19. Mexico Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 20. Mexico Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 21. Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 22. Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 23. Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 24. Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 25. Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 26. Germany Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 27. Germany Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 28. Germany Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 29. Germany Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 30. Germany Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 31. UK Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 32. UK Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 33. UK Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 34. UK Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 35. UK Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 36. France Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 37. France Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 38. France Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 39. France Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 40. France Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 41. Spain Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 42. Spain Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 43. Spain Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 44. Spain Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 45. Spain Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 46. Italy Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 47. Italy Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 48. Italy Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 49. Italy Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 50. Italy Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 52. Rest of Europe Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 53. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Europe Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Europe Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 56. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 57. Asia Pacific Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 58. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 59. Asia Pacific Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 60. Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 61. China Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 62. China Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 63. China Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 64. China Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 65. China Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 66. Japan Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 67. Japan Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 68. Japan Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 69. Japan Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 70. Japan Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 71. India: R&D spending of Pharmaceutical companies (2010 & 2017)
Table 72. India Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 73. India Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 74. India Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 75. India Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 76. India Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 77. South Korea Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 78. South Korea Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 79. South Korea Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 80. South Korea Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 81. South Korea Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 82. Australia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 83. Australia Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 84. Australia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 85. Australia Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 86. Australia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 87. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 88. Rest of Asia Pacific Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 89. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 90. Rest of Asia Pacific Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 91. Rest of Asia Pacific Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 92. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 93. Middle East & Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 94. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 95. Middle East & Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 96. Middle East & Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 97. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 98. Saudi Arabia Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 99. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 100. Saudi Arabia Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 101. Saudi Arabia Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 102. UAE Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 103. UAE Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 104. UAE Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 105. UAE Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 106. UAE Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 107. South Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 108. South Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 109. South Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 110. South Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 111. South Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 112. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 113. Rest of Middle East and Africa Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 114. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 115. Rest of Middle East and Africa Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 116. Rest of Middle East and Africa Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 117. South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 118. South and Central America Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 119. South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 120. South and Central America Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 121. South and Central America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 122. Brazil Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 123. Brazil Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 124. Brazil Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 125. Brazil Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 126. Brazil Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 127. Argentina Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 128. Argentina Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 129. Argentina Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 130. Argentina Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 131. Argentina Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 132. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 133. Rest of South and Central America Biologics Market – Revenue and Forecast to 2028 (USD Million)
Table 134. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 135. Rest of South and Central America Process Development Market – Revenue and Forecast to 2028 (USD Million)
Table 136. Rest of South and Central America Biopharmaceutical Contract Manufacturing Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 137. Organic Developments Done By Companies
Table 138. Inorganic Developments Done By Companies
Table 139. Glossary of Terms, Biopharmaceutical Contract Manufacturing Market